Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SGE1 / Re: Two Considerations - 80% of Revenue going to TPL - badger
24
Mar 24, 2010 11:58AM
8
Mar 24, 2010 12:50PM
1
Mar 24, 2010 01:05PM
3
Mar 24, 2010 01:43PM
2
Mar 24, 2010 01:56PM
4
Mar 24, 2010 04:10PM
1
Mar 24, 2010 04:36PM

According to the SEC filings, PDS gets nearly 84% of the licensing revenue. Not sure where you're getting your percentages or your info:

See the chart below:


MMP revs:

Prior to Merger 2006 2007 2008 2009 2010 Totals
Revenues $23,050,000 $60,000,000 $110,878,985 $ 59,282,971 $29,392,424 $11,023,655 $293,628,035
Operating expenses $ - $ 4,486,955 $ 12,189,575 $ 18,627,032 $ 7,793,472 $ 4,035,901 $ 47,132,935
Operating income $23,050,000 $55,513,045 $ 98,689,410 $ 40,655,939 $21,598,952 $ 6,987,754 $246,495,100
Interest income $ - $ 183,682 $ 421,407 $ 216,902 $ 58,987 $ 380 $ 881,358
Income before Taxes $23,050,000 $55,696,727 $ 99,110,817 $ 40,872,841 $21,657,939 $ 6,988,134 $247,376,458
Provision for Taxes $ - $ - $ 11,790 $ 11,790 $ 11,790 $ - $ 35,370
Net Income $23,050,000 $55,696,727 $ 99,099,027 $ 40,861,051 $21,646,149 $ 6,988,134 $247,341,088
Moore & TPL's Portion $11,525,000 $27,848,364 $ 49,549,514 $ 20,430,526 $10,823,075 $ 3,494,067 $123,670,544
PTSC's Portion $11,525,000 $27,848,364 $ 49,549,514 $ 20,430,526 $10,823,075 $ 3,494,067 $123,670,544
5
Mar 24, 2010 05:52PM
2
Mar 24, 2010 06:21PM
6
Mar 24, 2010 07:02PM
1
Mar 24, 2010 08:21PM
Share
New Message
Please login to post a reply